Почетна › Рак простате › Оклахома › Oklahoma City
Kliničke studije za Рак простате u gradu Oklahoma City, OK
22 studija za Рак простате traži učesnike na lokacijama u gradu Oklahoma City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- University of Oklahoma Health Sciences Center, Oklahoma City
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- University of Oklahoma Health Sciences Center, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Mercy Hospital Oklahoma City, Oklahoma City
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Тражи се учесникФаза 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Тражи се учесникФаза 3
- Hightower Clinical, Oklahoma City
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Тражи се учесникФаза 3
- OU Health Medical Center, Oklahoma City
- OU Health Stephenson Cancer Center, Oklahoma City
Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)
Тражи се учесникОпсервациона студија
- OU Health Stephenson Cancer Center, Oklahoma City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- University of Oklahoma, Oklahoma City
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Тражи се учесникФаза 3
- Oklahoma Proton Center, Oklahoma City
Protoacoustic Imaging For 3D Mapping
Тражи се учесникОпсервациона студија
- OU Health Stephenson Cancer Center, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
Тражи се учесник
- University of Oklahoma HSC, Oklahoma City
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Тражи се учесникФаза 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Тражи се учесникОпсервациона студија
- OU Health Stephenson Cancer Center, Oklahoma City
Connect2Care: Prostate Cancer Education and Screenings for African American Men
Тражи се учесник
- TSET Health Promotion Research Center, Oklahoma City
Studije za Рак простате u drugim gradovima
- New York City, NY101 студија
- Houston, TX73 студија
- Los Angeles, CA64 студија
- Boston, MA56 студија
- Seattle, WA45 студија
- St. Louis, MO45 студија
- Chicago, IL45 студија
- Baltimore, MD45 студија
- San Francisco, CA44 студија
- Philadelphia, PA41 студија
- Nashville, TN40 студија
- Washington, DC39 студија
Ostale studije u gradu Oklahoma City
- Немалоклетни карцином плућа32 студија
- Рак јајника29 студија
- Карцином ендометријума28 студија
- Колоректални карцином22 студија
- Рак плућа20 студија
- Рак дојке18 студија
- Метастатски карцином17 студија
- Akutna mijeloidna leukemija15 студија
- Рак (све врсте)15 студија
- Плоскоклеточни карцином главе и врата14 студија
- Рак бешике11 студија
- Рак панкреаса11 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.